Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

This study has been terminated.
(The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.)
Sponsor:
Collaborators:
Friedreich's Ataxia Research Alliance
Pfizer
Information provided by (Responsible Party):
University of South Florida
ClinicalTrials.gov Identifier:
NCT00803868
First received: December 4, 2008
Last updated: July 23, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)